The Effect of Supervised Exercise on Physical Fitness and Energy Expenditure in Post Bariatric Surgery Patients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00793832
Recruitment Status :
First Posted : November 19, 2008
Last Update Posted : July 1, 2013
University of Texas Southwestern Medical Center
Information provided by (Responsible Party):
Abhimanyu Garg, University of Texas Southwestern Medical Center
It is hypothesized that the patients in the EXDA group will be able to complete a structured exercise program at a level sufficient to accumulate at least 2000 kcal per week, and that the structured endurance activity will increase their physical fitness and total daily energy expenditure compared to the DA group.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 70 Years (Adult, Senior)
Sexes Eligible for Study:
Accepts Healthy Volunteers:
RYGB or GB surgery patients who are at least 12 weeks post surgery
BMI of 40 or more
sedentary lifestyle (energy expenditure of <35 kcal/kg/day measured by 7-day physical activity recall and no regular moderate physical activity exceeding 20 min/day within the previous 3 months)
willingness to alter physical activity in accordance with the intervention programs
English or Spanish speaking.
body weight > 180 kg
uncontrolled hypertension (resting DBP >100 or SBP >180 mm of Hg)
visual or hearing impairment
functional limitations (difficulty walking one-quarter mile or climbing 10 stairs)
abnormal ECG on VO2max test ( >1 mm ST segment depression at < 5 METS or with symptoms such as atrial fibrillation, complex ventricular arrhythmias and 3rd degree atrioventricular block)
known liver disease due to causes other than nonalcoholic steatohepatitis (liver transaminases > 2.5 times the upper limits of normal [SGPT>105 U/L, SGPT>120 U/L] or total bilirubin >1.5 mg/dL)
hematocrit of less than 30%
current alcohol abuse (>7 drinks or 210 g/wk for women and >14 drinks or 420 g/wk for men)
recreational drug abuse
current use of any drugs capable of inducing weight loss (e.g., orlistat, sibutramine, topiramate, etc.)
major neuro-psychiatric illnesses impeding competence or compliance
untreated thyroid disorders such as hypothyroidism and hyperthyroidism; and 17) bariatric surgical complications including anastomotic leak, wound complications, thrombotic disorders, intestinal obstruction, stomal complications, GI bleeding, recurrent severe abdominal pain, bilious vomiting.